Patents by Inventor Chimanlall Goolcharran

Chimanlall Goolcharran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Coated tablet formulations and uses thereof
    Patent number: 8790708
    Abstract: The present invention provides coated tablet formulations comprising neratinib maleate, and improved methods for making such coated tablets.
    Type: Grant
    Filed: August 21, 2013
    Date of Patent: July 29, 2014
    Assignee: Wyeth LLC
    Inventors: Muhammad Ashraf, Mainuddin Mahmud, Chimanlall Goolcharran, Krishnendu Ghosh, Arwinder Singh Nagi
  • COATED TABLET FORMULATIONS AND USES THEREOF
    Publication number: 20140004184
    Abstract: The present invention provides coated tablet formulations comprising neratinib maleate, and improved methods for making such coated tablets.
    Type: Application
    Filed: August 21, 2013
    Publication date: January 2, 2014
    Applicant: Wyeth LLC
    Inventors: Muhammad Ashraf, Mainuddin Mahmud, Chimanlall Goolcharran, Krishnendu Ghosh, Arwinder Singh Nagi
  • Coated tablet formulations and uses thereof
    Patent number: 8518446
    Abstract: The present invention provides coated tablet formulations comprising neratinib maleate, and improved methods for making such coated tablets.
    Type: Grant
    Filed: November 5, 2010
    Date of Patent: August 27, 2013
    Assignee: Wyeth LLC
    Inventors: Muhammad Ashraf, Mainuddin Mahmud, Chimanlall Goolcharran, Krishnendu Ghosh, Arwinder Singh Nagi
  • COATED TABLET FORMULATIONS AND USES THEREOF
    Publication number: 20110111018
    Abstract: The present invention provides coated tablet formulations comprising neratinib maleate, and improved methods for making such coated tablets.
    Type: Application
    Filed: November 5, 2010
    Publication date: May 12, 2011
    Applicant: Wyeth LLC
    Inventors: Muhammad Ashraf, Mainuddin Mahmud, Chimanlall Goolcharran, Krishnendu Ghosh, Arwinder Singh Nagi
  • Stable liquid IL-1 antagonist formulations
    Patent number: 7655758
    Abstract: Formulations of an interleukin-1 (IL-1) antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the IL-1 antagonist is an IL-1 trap composed of a dimer of two fusion proteins having an amino acid sequence of SEQ ID NO: 10. Stable liquid formulations made with and without sodium chloride, and made with phosphate or histidine buffer, are provided.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: February 2, 2010
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Daniel Dix, Katherine Bowers, Chimanlall Goolcharran, Leu-Fen H. Lin
  • IL-1 antagonist formulations
    Patent number: 7572893
    Abstract: Formulations of an interleukin-1 (IL-1) antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the IL-1 antagonist is an IL-1 trap composed of a dimer of two fusion protein having an amino acid sequence selected from the group consisting of SEQ ID NO: 10.
    Type: Grant
    Filed: May 18, 2007
    Date of Patent: August 11, 2009
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Daniel Dix, Katherine Bowers, Chimanlall Goolcharran, Leu-Fen H. Lin
  • SUSTAINED-RELEASE TABLET FORMULATIONS OF PIPERAZINE-PIPERIDINE ANTAGONISTS AND AGONISTS OF THE 5-HT1A RECEPTOR HAVING ENHANCED INTESTINAL DISSOLUTION
    Publication number: 20080226714
    Abstract: The present invention relates to sustained-release tablet formulations of piperazine-piperidine compounds, which can be useful in treating central nervous system disorders; to processes for their preparation; and to methods of using them.
    Type: Application
    Filed: February 15, 2008
    Publication date: September 18, 2008
    Applicant: WYETH
    Inventors: Hong Wen, Chimanlall Goolcharran, Krishnendu Ghosh, Arwinder Nagi
  • Stable Liquid IL-1 Antagonist Formulations
    Publication number: 20080188817
    Abstract: Formulations of an interleukin-1 (IL-1) antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the IL-1 antagonist is an IL-1 trap composed of a dimer of two fusion proteins having an amino acid sequence of SEQ ID NO: 10. Stable liquid formulations made with and without sodium chloride, and made with phosphate or histidine buffer, are provided.
    Type: Application
    Filed: March 14, 2008
    Publication date: August 7, 2008
    Inventors: Daniel Dix, Katherine Bowers, Chimanlall Goolcharran, Leu-Fen H. Lin
  • IL-1 antagonist formulations
    Patent number: 7365165
    Abstract: Formulations of an interleukin-1 (IL-1) antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the IL-1 antagonist is an IL-1 trap composed of a dimer of two fusion protein having an amino acid sequence selected from the group consisting of SEQ ID NO:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, and 26. Most preferably, the fusion protein has the sequence of SEQ ID NO:10.
    Type: Grant
    Filed: August 17, 2005
    Date of Patent: April 29, 2008
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Daniel Dix, Katherine Bowers, Chimanlall Goolcharran
  • IL-1 Antagonist Formulations
    Publication number: 20080015148
    Abstract: Formulations of an interleukin-1 (IL-1) antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the IL-1 antagonist is an IL-1 trap composed of a dimer of two fusion protein having an amino acid sequence selected from the group consisting of SEQ ID NO: 10.
    Type: Application
    Filed: May 18, 2007
    Publication date: January 17, 2008
    Inventors: Daniel Dix, Katherine Bowers, Chimanlall Goolcharran, Leu-Fen Lin
  • IL-1 antagonist formulations
    Publication number: 20060040852
    Abstract: Formulations of an interleukin-1 (IL-1) antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the IL-1 antagonist is an IL-1 trap composed of a dimer of two fusion protein having an amino acid sequence selected from the group consisting of SEQ ID NO:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, and 26. Most preferably, the fusion protein has the sequence of SEQ ID NO:10.
    Type: Application
    Filed: August 17, 2005
    Publication date: February 23, 2006
    Inventors: Daniel Dix, Katherine Bowers, Chimanlall Goolcharran